German American Bancorp, Inc. Eli Lilly & CO Transaction History

German American Bancorp, Inc.

$943 Million
Q3 2024

A detailed history of German American Bancorp, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, German American Bancorp, Inc. holds 2,284 shares of LLY stock, worth $1.66 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,284

Previous 2,248 1.6%

Holding current value

$1.66 Million

Previous $2.04 Million 0.59%

% of portfolio

0.21%

Previous 0.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $27,797 - $34,560	36 Added 1.6%	2,284 $2.02 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $72,487 - $90,904	100 Added 4.66%	2,248 $2.04 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $4,145 - $5,545	-7 Reduced 0.32%	2,148 $1.67 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $148,103 - $174,594	282 Added 15.06%	2,155 $1.26 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $1.3 Million - $1.8 Million	-3,000 Reduced 61.56%	1,873 $1.01 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $3,507 - $4,689	10 Added 0.21%	4,873 $2.29 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $15,434 - $17,984	-48 Reduced 0.98%	4,863 $1.78 Million
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $889,440 - $1.01 Million	3,000 Added 156.99%	4,911 $1.59 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2,229 - $2,618	-8 Reduced 0.42%	1,911 $620,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $88,243 - $109,664	376 Added 24.37%	1,919 $550,000
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $1,314 - $1,701	8 Added 0.52%	1,543 $288,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $215,259 - $284,839	-1,650 Reduced 51.81%	1,535 $259,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $21,933 - $25,369	150 Added 4.94%	3,185 $471,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $3,274 - $3,940	24 Added 0.8%	3,035 $498,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $321,544 - $349,757	3,011 New	3,011 $337,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $189,007 - $220,619	-1,706 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $189,894 - $223,520	1,706 New	1,706 $221,000

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of German American Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on German American Bancorp, Inc. with notifications on news.

Account

German American Bancorp, Inc. Eli Lilly & CO Transaction History